Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2010

View Archived Issues

PBT-434 prevents nigral cell death in models of Parkinson's disease

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Studies further characterize HIV integrase inhibitor S/GSK-1349572

Multiple studies describe preclinical profile of antibacterial polypeptide NZ-17074

Helix BioPharma completes GLP toxicology studies of L-DOS-47

Roskamp Institute to begin trials of RCP-006 for treatment of Alzheimer's disease

Genmab and Lundbeck to collaborate on human antibodies for CNS disorders

Merck Frosst discovers novel acyl-CoA desaturase inhibitors

Bayer Schering Pharma discovers vasopressin receptor inhibitors

E.U. concerned member states reach positive agreement for approval of Vimovo

Novel GlyT-1 inhibitors synthesized at sanofi-aventis

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Boehringer Ingelheim discloses new FADK 1 inhibitors

Cell Cure Neurosciences receives investments to develop stem cell treatments

SEPS Pharma patents new antifungal fluconazole derivatives

Tesetaxel receives EMA orphan drug status for gastric cancer

EMA approves Twynsta single pill combination for high blood pressure

Pharmalink obtains FDA orphan drug designation for PL-56

Boehringer Ingelheim discontinues flibanserin development

Antisoma provides update in interim management statement

Alexza receives FDA complete response letter for AZ-004 NDA

Genentech begins phase II vismodegib trial in operable basal cell carcinoma

ESMO and Thomson Reuters collaborate on oncology web portal

Encouraging results reported for phase IIb trial of A-3309 in chronic idiopathic constipation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...